查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1404656

消费者基因体学市场规模、份额、趋势分析报告：按应用、地区、细分市场预测，2023-2030 年

Consumer Genomics Market Size, Share & Trends Analysis Report By Application (Genetic Relatedness, Ancestry, Diagnostics, Sports Nutrition & Health), By Region (North America, Europe), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

消费者基因组学市场成长与趋势：

Grand View Research, Inc.的最新报告显示，到2030年，全球消费者基因组学市场规模预计将达到72亿美元，2023年至2030年复合年增长率为24.8%。

消费者和医生对 DTC（直接面向消费者）套件的兴趣不断增加，DNA检测套组销量随之增加，以及个体化基因组学的上升趋势预计将在预测期内推动市场扩张。最常见的测试使用少量的基因变化来预测某些健康特征，发现通用特征并提供有关血统的提示。随着这些测试可以揭示的健康资讯变得更加多样化，越来越多的公司直接向消费者提供基因测试。

消费者和医生对 DTC套件的兴趣增加、技术进步、消费者基因组学应用的增加、政府支持政策以及个体化基因组学的上升趋势是推动市场扩张的主要因素。例如，根据 ScienceDirect 的报导，直接面向消费者 (DTC) 的检测将在 2022 年变得更加普及，因为无需医生处方笺即可购买。

COVID-19 大流行可能会增加人们对健康的兴趣，并鼓励探索消费者基因组学等新颖、前沿的方法。因此，基于DNA的研发和生物资讯学正在加大力度，旨在为COVID-19创造诊断工具和有效的治疗方法，预计市场在预测期内将保持显着的成长率。

消费者基因组学市场报告亮点

  • 由于涉及最常见的亲子鑑定类型，遗传相关部分在 2022 年收益占有率。
  • 溶解微针领域预计将在预测期内以最快的速度成长，因为它需要一个步骤，并且插入后无需移除微针。
  • FamilyTree DNA、AncestryDNA、23andMe, Inc. 和 MyHeritage 等公司提供多种父系和母系测试。这些测试提供了有关遗传关係和血统的负担得起的资讯。
  • 由于人们对 DTC 遗传学的认识不断增强，并且长期研究倡议的资金筹措，预计亚太地区在预测期内将经历最快的复合年增长率。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 产业分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影响分析

第四章消费者基因体学应用商业分析

  • 消费者基因体学市场：应用变异分析
  • 遗传相关性
    • 2018-2030 年遗传相关市场估计与预测
  • 祖先
    • 2018-2030 年 Ancestor 市场估计与预测
  • 生活方式、健康与营养
    • 2018-2030 年生活方式、健康和营养市场估计和预测
  • 诊断
    • 2018-2030 年诊断市场估计与预测
  • 运动营养与健康
    • 2018-2030年运动营养与健康市场估计与预测
  • 生殖健康
    • 2018-2030 年生殖健康市场估计与预测
  • 个人化医疗/药物基因测试
    • 2018-2030 年个人化医疗/药物基因学测试市场估计与预测
  • 其他的
    • 2018-2030 年其他应用市场估计与预测

第五章区域业务分析

  • 消费者基因体学市场：区域市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第六章竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介/名单
    • Ancestry
    • 23andMe, Inc.
    • Gene by Gene, Ltd.
    • Mapmygenome
    • Color Health, Inc.
    • Positive Biosciences, Ltd.
    • Futura Genetics
    • Helix OpCo LLC
    • MyHeritage Ltd.
    • Pathway Genomics
    • Veritas
    • Myriad Genetics, Inc.
    • Illumina, Inc.
    • Amgen, Inc.
    • Xcode Life
    • Diagnomics, Inc.
    • Toolbox Genomics
Product Code: GVR-2-68038-987-6

Consumer Genomics Market Growth & Trends:

The global consumer genomics market size is expected to reach USD 7.20 billion by 2030, registering a CAGR of 24.8% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rise in consumer and physician interest in direct-to-consumer (DTC) kits, coupled with a subsequent increase in the sales of DNA test kits, and the growing trend of personalized genomics, are expected to drive market expansion over the forecast period. The most common tests utilize a small number of genetic changes to predict certain health characteristics, reveal common traits, and provide ancestry hints. With the expansion of the variety of health information these tests can uncover, an increasing number of companies are offering genetic testing directly to consumers.

The surge in consumer and physician interest in DTC kits, technological improvements, an increase in consumer genomics applications, supportive governmental policies, and the growing trend of personalized genomics are the primary drivers of market expansion. For instance, according to a ScienceDirect article, direct-to-consumer (DTC) tests became more prevalent in 2022 as they could be purchased without a doctor's prescription.

The COVID-19 pandemichas heightened people's concerns about their health, potentially encouraging them to explore novel and cutting-edge methods like consumer genomics. Therefore, the market is expected to maintain its considerable growth rate over the forecast period due to the increasing efforts in DNA-based research and development, as well as bioinformatics, aimed at creating diagnostic tools and efficient therapies for COVID-19.

Consumer Genomics Market Report Highlights:

  • The genetic relatedness segment accounted for the largest revenue share in 2022 due to its involvement in the most common type of paternal testing
  • The dissolving microneedle segment is expected to grow at the fastest rate during the forecast period since it requires only one step, and the microneedle does not need to be removed after insertion
  • Companies such as FamilyTree DNA; AncestryDNA; 23andMe, Inc.; MyHeritage, and others offer several paternal and maternal tests. These tests provide information about genetic relations and ancestry at an affordable cost
  • Asia Pacific is anticipated to experience the fastest CAGR over the forecast period due to the increasing awareness related to DTC genetics and the availability of funding for long-term research initiatives

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segment & Scope
    • 1.1.1. Application
    • 1.1.2. Regional Scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information Or Data Analysis
    • 1.4.1. Data Analysis Model
  • 1.5. Market Scope & Segment Definition
  • 1.6. Market Model
    • 1.6.1. Market Study, By Company Market Share
    • 1.6.2. Regional Analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rise in interest of consumers & physicians in DTC kits & consequent rise in sales of DNA test kits
      • 3.2.1.2. Increase in access to DTC services due to reducing cost of genotyping
      • 3.2.1.3. Expansion in applications of DTC genetics
      • 3.2.1.3.1. Health testing
      • 3.2.1.3.2. Ancestry
      • 3.2.1.3.3. Genetic relatedness
      • 3.2.1.4. Significant investments & initiatives by companies to maintain their competitive edge in the market
      • 3.2.1.5. Growing trend of personalized genomics
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Ethical and clinical issues pertaining to the use of DTC products & personalized treatment
      • 3.2.2.2. Misleading results create challenges in adoption of home-based genetic tests
      • 3.2.2.3. Regulatory challenges pertaining to the use of DTC genetic tests
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Consumer Genomics Application Business Analysis

  • 4.1. Consumer Genomics Market: Application Movement Analysis
  • 4.2. Genetic Relatedness
    • 4.2.1. Genetic Relatedness Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Ancestry
    • 4.3.1. Ancestry Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Lifestyle, Wellness, & Nutrition
    • 4.4.1. Lifestyle, Wellness, & Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Diagnostics
    • 4.5.1. Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Sports Nutrition & Health
    • 4.6.1. Sports Nutrition & Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Reproductive Health
    • 4.7.1. Reproductive Health Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Personalized medicine & Pharmacogenetic testing
    • 4.8.1. Personalized medicine & Pharmacogenetic testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Other Application Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Regional Business Analysis

  • 5.1. Consumer Genomics Market: Regional Market Snapshot
  • 5.2. North America
    • 5.2.1. North America Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.2.2. U.S.
      • 5.2.2.1. Key Country Dynamics
      • 5.2.2.2. Target Disease Prevalence
      • 5.2.2.3. Competitive Scenario
      • 5.2.2.4. Regulatory Framework
      • 5.2.2.5. U.S. Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.2.3. Canada
      • 5.2.3.1. Key Country Dynamics
      • 5.2.3.2. Target Disease Prevalence
      • 5.2.3.3. Competitive Scenario
      • 5.2.3.4. Regulatory Framework
      • 5.2.3.5. Canada Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.3. Europe
    • 5.3.1. Europe Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.2. UK
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Target Disease Prevalence
      • 5.3.2.3. Competitive Scenario
      • 5.3.2.4. Regulatory Framework
      • 5.3.2.5. UK Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Target Disease Prevalence
      • 5.3.3.3. Competitive Scenario
      • 5.3.3.4. Regulatory Framework
      • 5.3.3.5. Germany Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.4. France
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Target Disease Prevalence
      • 5.3.4.3. Competitive Scenario
      • 5.3.4.4. Regulatory Framework
      • 5.3.4.5. France Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.5. Italy
      • 5.3.5.1. Key Country Dynamics
      • 5.3.5.2. Target Disease Prevalence
      • 5.3.5.3. Competitive Scenario
      • 5.3.5.4. Regulatory Framework
      • 5.3.5.5. Italy Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.6. Spain
      • 5.3.6.1. Key Country Dynamics
      • 5.3.6.2. Target Disease Prevalence
      • 5.3.6.3. Competitive Scenario
      • 5.3.6.4. Regulatory Framework
      • 5.3.6.5. Spain Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.7. Denmark
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Target Disease Prevalence
      • 5.3.7.3. Competitive Scenario
      • 5.3.7.4. Regulatory Framework
      • 5.3.7.5. Denmark Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.8. Sweden
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Target Disease Prevalence
      • 5.3.8.3. Competitive Scenario
      • 5.3.8.4. Regulatory Framework
      • 5.3.8.5. Sweden Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.3.9. Norway
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Target Disease Prevalence
      • 5.3.9.3. Competitive Scenario
      • 5.3.9.4. Regulatory Framework
      • 5.3.9.5. Norway Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Target Disease Prevalence
      • 5.4.2.3. Competitive Scenario
      • 5.4.2.4. Regulatory Framework
      • 5.4.2.5. Japan Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Target Disease Prevalence
      • 5.4.3.3. Competitive Scenario
      • 5.4.3.4. Regulatory Framework
      • 5.4.3.5. China Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Target Disease Prevalence
      • 5.4.4.3. Competitive Scenario
      • 5.4.4.4. Regulatory Framework
      • 5.4.4.5. India Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.5. Australia
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Target Disease Prevalence
      • 5.4.5.3. Competitive Scenario
      • 5.4.5.4. Regulatory Framework
      • 5.4.5.5. Australia Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.6. Switzerland
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Target Disease Prevalence
      • 5.4.6.3. Competitive Scenario
      • 5.4.6.4. Regulatory Framework
      • 5.4.6.5. Switzerland Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Target Disease Prevalence
      • 5.4.7.3. Competitive Scenario
      • 5.4.7.4. Regulatory Framework
      • 5.4.7.5. Thailand Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.4.8. South Korea
      • 5.4.8.1. Key Country Dynamics
      • 5.4.8.2. Target Disease Prevalence
      • 5.4.8.3. Competitive Scenario
      • 5.4.8.4. Regulatory Framework
      • 5.4.8.5. South Korea Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Target Disease Prevalence
      • 5.5.2.3. Competitive Scenario
      • 5.5.2.4. Regulatory Framework
      • 5.5.2.5. Brazil Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.3. Mexico
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Target Disease Prevalence
      • 5.5.3.3. Competitive Scenario
      • 5.5.3.4. Regulatory Framework
      • 5.5.3.5. Mexico Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.5.4. Argentina
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Target Disease Prevalence
      • 5.5.4.3. Competitive Scenario
      • 5.5.4.4. Regulatory Framework
      • 5.5.4.5. Argentina Consumer Genomics Market, 2018 - 2030 (USD Million)
  • 5.6. MEA
    • 5.6.1. MEA Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Target Disease Prevalence
      • 5.6.2.3. Competitive Scenario
      • 5.6.2.4. Regulatory Framework
      • 5.6.2.5. South Africa Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Target Disease Prevalence
      • 5.6.3.3. Competitive Scenario
      • 5.6.3.4. Regulatory Framework
      • 5.6.3.5. Saudi Arabia Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Target Disease Prevalence
      • 5.6.4.3. Competitive Scenario
      • 5.6.4.4. Regulatory Framework
      • 5.6.4.5. UAE Consumer Genomics Market, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Target Disease Prevalence
      • 5.6.5.3. Competitive Scenario
      • 5.6.5.4. Regulatory Framework
      • 5.6.5.5. Kuwait Consumer Genomics Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Company Categorization
  • 6.2. Strategy Mapping
  • 6.3. Company Market Share Analysis, 2022
  • 6.4. Company Profiles/Listing
    • 6.4.1. Ancestry
      • 6.4.1.1. Overview
      • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Strategic Initiatives
    • 6.4.2. 23andMe, Inc.
      • 6.4.2.1. Overview
      • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Strategic Initiatives
    • 6.4.3. Gene by Gene, Ltd.
      • 6.4.3.1. Overview
      • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Strategic Initiatives
    • 6.4.4. Mapmygenome
      • 6.4.4.1. Overview
      • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Strategic Initiatives
    • 6.4.5. Color Health, Inc.
      • 6.4.5.1. Overview
      • 6.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Strategic Initiatives
    • 6.4.6. Positive Biosciences, Ltd.
      • 6.4.6.1. Overview
      • 6.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Strategic Initiatives
    • 6.4.7. Futura Genetics
      • 6.4.7.1. Overview
      • 6.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Strategic Initiatives
    • 6.4.8. Helix OpCo LLC
      • 6.4.8.1. Overview
      • 6.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Strategic Initiatives
    • 6.4.9. MyHeritage Ltd.
      • 6.4.9.1. Overview
      • 6.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Strategic Initiatives
    • 6.4.10. Pathway Genomics
      • 6.4.10.1. Overview
      • 6.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Strategic Initiatives
    • 6.4.11. Veritas
      • 6.4.11.1. Overview
      • 6.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.11.3. Product Benchmarking
      • 6.4.11.4. Strategic Initiatives
    • 6.4.12. Myriad Genetics, Inc.
      • 6.4.12.1. Overview
      • 6.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.12.3. Product Benchmarking
      • 6.4.12.4. Strategic Initiatives
    • 6.4.13. Illumina, Inc.
      • 6.4.13.1. Overview
      • 6.4.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.13.3. Product Benchmarking
      • 6.4.13.4. Strategic Initiatives
    • 6.4.14. Amgen, Inc.
      • 6.4.14.1. Overview
      • 6.4.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.14.3. Product Benchmarking
      • 6.4.14.4. Strategic Initiatives
    • 6.4.15. Xcode Life
      • 6.4.15.1. Overview
      • 6.4.15.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.15.3. Product Benchmarking
      • 6.4.15.4. Strategic Initiatives
    • 6.4.16. Diagnomics, Inc.
      • 6.4.16.1. Overview
      • 6.4.16.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.16.3. Product Benchmarking
      • 6.4.16.4. Strategic Initiatives
    • 6.4.17. Toolbox Genomics
      • 6.4.17.1. Overview
      • 6.4.17.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 6.4.17.3. Product Benchmarking
      • 6.4.17.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 List of abbreviation
  • Table 3 Global consumer genomics market, by region, 2018 - 2030 (USD Million)
  • Table 4 North America consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 5 North America consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 7 Canada consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 8 Europe consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 9 Europe consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 10 UK consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Germany consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 12 France consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 13 Italy consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 14 Spain consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Denmark consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 16 Sweden consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 17 Norway consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 20 Japan consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 21 China consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 22 India consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Australia consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 24 Switzerland consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 25 Thailand consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 26 South Korea consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Latin America consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 29 Brazil consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Mexico consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 31 Argentina consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa consumer genomics market, by country, 2018 - 2030 (USD Million)
  • Table 33 Middle East & Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 34 South Africa consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 35 Saudi Arabia consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 36 UAE consumer genomics market, by application, 2018 - 2030 (USD Million)
  • Table 37 Kuwait consumer genomics market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Consumer Genomics market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 PESTEL analysis
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Global Consumer Genomics market: Application movement analysis
  • Fig. 15 Global Consumer Genomics market, for genetic relatedness, 2018 - 2030 (USD Million)
  • Fig. 16 Global Consumer Genomics market, for ancestry, 2018 - 2030 (USD Million)
  • Fig. 17 Global Consumer Genomics market, for lifestyle, wellness, & nutrition, 2018 - 2030 (USD Million)
  • Fig. 18 Global Consumer Genomics market, for diagnostics, 2018 - 2030 (USD Million)
  • Fig. 19 Global Consumer Genomics market, for sports nutrition & health, 2018 - 2030 (USD Million)
  • Fig. 20 Global Consumer Genomics market, for reproductive health, 2018 - 2030 (USD Million)
  • Fig. 21 Global Consumer Genomics market, for personalized medicine & pharmacogenetic testing, 2018 - 2030 (USD Million)
  • Fig. 22 Global Consumer Genomics market, for other applications, 2018 - 2030 (USD Million)
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 Regional outlook, 2022 & 2030
  • Fig. 25 Global Consumer Genomics market: Region movement analysis
  • Fig. 26 North America Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 32 France Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 40 China Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 41 India Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 43 Switzerland Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 44 South Korea Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 46 Latin America Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 47 Brazil Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 49 Argentina Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 50 Middle East and Africa Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 51 South Africa Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 53 UAE Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 54 Kuwait Consumer Genomics market, 2018 - 2030 (USD Million)